app

MDMA Papers Retracted; School Bans Black Clothing; TikTok and Disordered Eating

— News and commentary from the psychiatry world

MedpageToday
Illustration of a brain shaped maze.

On the heels of FDA's rejection of midomafetamine (MDMA) for post-traumatic stress disorder (PTSD), the journal Psychopharmacology on MDMA-assisted therapy over data integrity concerns. (New York Times)

Depressive symptoms in into young adulthood, a cohort study suggested. "Given this persistence, reducing the onset of depressive symptoms through primary prevention and mental health resources during the adolescent years is critical," the study authors wrote in JAMA Network Open.

Google is teaming up with singer and actress high school mental health initiatives. (AP)

A Texas middle school banned students from , citing its association with depression and mental health issues. (People)

Nearly one in 10 adults with chronic pain and opioid use disorder, according to a systematic review and meta-analysis. (Addiction)

An observational study suggested that participation in the Early Assessment Service for Young People With Early Psychosis program was tied to in patients with first-episode schizophrenia. (JAMA Network Open)

Children who survived the shooting at the in February have reported panic attacks and sleep issues. (KFF Health News)

Although no insurers have yet agreed to cover Otsuka's prescription app Rejoyn , the company said the 6-week treatment will cost an introductory price of $50 out-of-pocket plus the cost of the optional Wheel Health consultation with a clinician who can prescribe it. (STAT)

Women ages 18 to 28 who spent a lot of time scrolling pro-anorexia content on TikTok reported on average, a study in PLOS One suggested.

Nearly 60% of patients without severe mental disorders met the following 1 week of inpatient cognitive behavioral therapy for insomnia. (Frontiers in Psychiatry)

"The Kardashians" star Kylie Jenner recently opened up about her . (ABC News)

Among younger veterans with type 2 diabetes and PTSD followed for up to 9 years, was associated with lower risks of starting insulin and all-cause mortality. (JAMA Network Open)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.